Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ab Initio Biotherapeutics

Ab Initio Biotherapeutics
2015 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$12M LATEST DEAL AMOUNT
Description

Developer of protein engineering platform designed for the discovery of therapeutic antibodies against difficult-to-access cellular targets. The company's platform allows for targeting multi-transmembrane and facilitates antibody generation relevant to a wide array of therapeutic indications including neurological, cardiovascular, endocrine and gastrointestinal disorders, enabling doctors to optimize the solubility and stability of drugs.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 280 Utah Avenue
  • South San Francisco, CA 94080
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ab Initio Biotherapeutics’s full profile, request a free trial.

Ab Initio Biotherapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Jul-2019 $12M 000 0000 Completed Generating Revenue
3. Corporate 13-Dec-2016 000 Completed Startup
2. Angel (individual) $2M $2M Completed Startup
1. Accelerator/Incubator 03-Mar-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ab Initio Biotherapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator 000 0000 000000 0
Pfizer Corporation Minority 000 0000 000000 0
Polaris Partners Venture Capital Minority 000 0000 000000 0

Ab Initio Biotherapeutics Executive Team (6)

Name Title Board
Seat
Contact
Info
Kenneth Lin MD Co-Founder, President & Chief Executive Officer
Roy Maute Ph.D Co-Founder & Head of Research
Aaron Ring MD Co-Founder
Aashish Manglik MD Co-Founder
Andrew Kruse Ph.D Co-Founder
You’re viewing 5 of 6 executives. Get the full list »

Ab Initio Biotherapeutics Board Members (1)

Name Representing Role Since Contact
Info
Robert Booth Ph.D Self Co-Founder & Executive Chairman 000 0000